$0.4127
-0.0151[-3.53%]
At close: Apr 24
$0.4127
0[0.00%]
After Hours: 6:12PM EDT
Redhill Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Redhill Biopharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
06/10/2024 | AM | RDHL | Q1 | -$0.05 | — | — | — | $3.60M | — | — | — | Get Alert |
05/07/2024 | AM | RDHL | Q3 | -$2.40 | — | — | — | $17.55M | — | — | — | Get Alert |
04/08/2024 | AM | RDHL | Q4 | $0.00 | — | — | — | $12.80M | — | — | — | Get Alert |
08/17/2023 | AM | RDHL | Q2 | -$0.80 | — | $0.09 | — | $18.35M | — | $1.80M | — | Get Alert |
06/12/2023 | AM | RDHL | Q1 | $0.04 | — | -$0.05 | — | $13.10M | — | $3.60M | — | Get Alert |
04/28/2023 | AM | RDHL | Q4 | -$20.00 | — | $0.00 | — | $22.07M | $18.10M | $12.80M | -29.29% | Get Alert |
11/29/2022 | AM | RDHL | Q3 | -$2.00 | — | -$2.40 | — | $21.61M | $21.24M | $17.55M | — | Get Alert |
11/07/2022 | AM | RDHL | Q2 | -$2.40 | — | -$0.80 | — | $21.50M | — | $18.35M | — | Get Alert |
06/23/2022 | AM | RDHL | Q1 | -$2.00 | -$9.20 | -$12.00 | -30.43% | $20.57M | $24.30M | $18.24M | -24.95% | Get Alert |
03/17/2022 | AM | RDHL | Q4 | -$2.80 | -$13.20 | -$20.00 | -51.52% | $21.46M | $24.08M | $22.07M | -8.34% | Get Alert |
11/30/2021 | AM | RDHL | Q3 | -$2.00 | -$8.40 | -$20.00 | -138.10% | $20.94M | $24.52M | $21.61M | -11.87% | Get Alert |
08/26/2021 | AM | RDHL | Q2 | $1.60 | -$4.80 | -$2.40 | 50.00% | $20.90M | $25.02M | $21.50M | -14.06% | Get Alert |
05/27/2021 | AM | RDHL | Q1 | -$2.00 | -$13.60 | -$2.00 | 85.29% | $1.06M | $22.70M | $20.57M | -9.36% | Get Alert |
03/18/2021 | AM | RDHL | Q4 | $1.20 | -$9.60 | -$2.80 | 70.83% | $1.59M | $26.03M | $21.46M | -17.55% | Get Alert |
11/12/2020 | AM | RDHL | Q3 | -$1.20 | -$6.40 | -$2.00 | 68.75% | $1.40M | $25.37M | $20.94M | -17.45% | Get Alert |
08/13/2020 | AM | RDHL | Q2 | -$1.60 | -$2.80 | -$1.60 | 42.86% | $1.56M | $22.99M | $20.90M | -9.10% | Get Alert |
05/27/2020 | AM | RDHL | Q1 | -$1.20 | -$9.60 | -$2.00 | 79.17% | $1.74M | $4.38M | $1.06M | -75.89% | Get Alert |
03/04/2020 | AM | RDHL | Q4 | -$1.20 | -$9.60 | $1.20 | 112.50% | $1.36M | $2.15M | $1.59M | -26.05% | Get Alert |
11/19/2019 | AM | RDHL | Q3 | -$1.60 | -$15.20 | -$1.20 | 92.11% | $2.21M | $1.77M | $1.40M | -20.85% | Get Alert |
Redhill Biopharma (RDHL) is scheduled to report earnings on June 10, 2024. The last reported earnings were for reported on April 8, 2024 for Q4.
The Actual EPS was $0.00, which hit the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.